Sta Znaci DOUBLE-BLIND STUDY na Hrvatskom - Hrvatski Prijevod

• dvostruko slijepom ispitivanju
• dvostruko slijepom istraživanju studiji
• dvostruko slijepoj studiji
• dvostruko slijepo ispitivanje

Primjeri korištenja Double-blind study na Engleski i njihovi prijevodi na Hrvatskom

Each double-blind study period lasted 2 weeks.
Svako razdoblje dvostruko slijepog ispitivanja trajalo je 2 tjedna.

Only one death occurred in each treatment group during the 6-month double-blind study period, therefore no conclusion can be drawn on survival.
Došlo je do jednog smrtnog slučaja u svakoj skupini tijekom šestomjesečne dvostruko slijepe studije pa se ne može donijeti zaključak o utjecaju na preživljenje.

A double-blind study was carried out in 209 subjects who were randomly allocated to two groups A and B.
U ovu dvostruko-slijepu studiju bilo je ukljueno 209 bolesnika koji su nasumce podijeljeni u dvije skupine A i B.

In a large multicentre, double-blind study, they examined 3,171 patients admitted in the acute phase of unstable angina or non-Q-wave myocardial infarction.
U velikom multicentričnom, dvostruko slijepom ispitivanju ispitan je 3171 bolesnik primljen u akutnoj fazi nestabilne angine pektoris ili infarkta miokarda bez Q zupca.

The double-blind study population comprised 409 patients of whom 272 received Xiapex 0.58 mg and 137 received placebo.
Populacija u dvostruko slijepim ispitivanjima sastojala se od 409 bolesnika od kojih je 272 primilo 0, 58 mg Xiapexa, a 137 placebo.

A randomised, placebo-controlled, double-blind study was conducted post-approval to evaluate the efficacy of palifermin given pre- or pre- and post- chemotherapy CT.
Nakon stavljanja lijeka u promet provedeno je randomizirano, placebom kontrolirano, dvostruko slijepo ispitivanje radi ocjenjivanja djelotvornosti palifermina primijenjenog prije ili i prije i nakon kemoterapije.

In the double-blind study SP513 Part I, 213 patients received rotigotine, 227 received ropinirole and 117 patients received placebo.
U dvostruko slijepom ispitivanju SP513 I dio 213 bolesnika primalo je rotigotin, 227 ropinirol i 117 placebo.

Oesophageal Candidiasis: In a randomised, double-blind study of micafungin versus fluconazole in the first-line treatment of oesophageal candidiasis, 518 patients received at least a single dose of study drug.
Ezofagealna kandidijaza: U randomiziranom, dvostruko slijepom ispitivanju mikafungina u usporedbi s flukonazolom, u prvoj liniji liječenja kandidijaze jednjaka, 518 bolesnika primilo je najmanje jednu dozu ispitivanog lijeka.

The double-blind study population comprised 832 male patients of whom 551 patients received Xiapex and 281 received placebo.
Populacija u dvostruko slijepim ispitivanjima sastojala se od 832 muška bolesnika od kojih je 551 bolesnik primio Xiapex, a 281 placebo.

In the double-blind study SP515, 201 patients received rotigotine, 200 received pramipexole and 100 patients received placebo.
U dvostruko-slijepom ispitivanju SP515 201 bolesnik primao je rotigotin, 200 je primalo pramipeksol i 100 bolesnika je primalo placebo.

In one double-blind study, patients with acute or chronic ear, nose or throat diseases found significant symptom regression with serrapeptase.
U jednoj dvostruko slijepoj studiji bolesnici s akutnim ili kroničnim bolestima uha, grla i nosa pronašli su značajnu regresiju simptoma serrapeptazom.

In a double-blind study in patients with PAH, macitentan 10 mg was associated with a mean decrease in haemoglobin versus placebo of 1 g/dL.
U dvostruko slijepom ispitivanju na bolesnicima s PAH-om, macitentan 10 mg povezan je s prosječnim padom koncentracije hemoglobina naspram placeba od 1 g/dl.

In a double-blind study, serrapeptase was found to reduce breast pain, breast swelling, and induration in 85.7% of the patients taking the supplement.
U dvostruko slijepoj studiji utvrđeno je da serrapeptaza smanjuje bol u dojkama, oticanje dojki i induriranje u 85,7% bolesnika koji uzimaju dodatak.

In a long-term double-blind study in patients with PAH, hypotension was reported for 7.0% and 4.4% of patients on macitentan 10 mg and placebo, respectively.
U dugoročnom dvostruko slijepom ispitivanju u bolesnika s PAH-om, hipotenzija je prijavljena za 7,0% bolesnika koji su primali 10 mg macitentana i 4,4% bolesnika koji su primali placebo.

In a randomized double-blind study(BR.21; Tarceva administered as second line therapy), rash(75%) and diarrhoea(54%) were the most commonly reported adverse drug reactions ADRs.
U randomiziranom, dvostruko slijepom ispitivanju(BR.21; Tarceva primjenjena kao druga linija terapije), najčešće prijavljivane nuspojave su bile osip(75%) i proljev 54.

In a 26-week double-blind study prolonged-release exenatide was compared to maximum daily doses of sitagliptin and pioglitazone in subjects also using metformin.
U 26-tjednom dvostruko slijepom ispitivanju eksenatid s produljenim oslobađanjem je uspoređivan s najvišim dnevnim dozama sitagliptina i pioglitazona u ispitanika koji su uzimali i metformin.

In a randomized, double-blind study, patients with 40% total body area burns were chosen to get basic burn care plus oxandrolone, or without oxandrolone.
U randomiziranom, dvostruko slijepom istraživanju studiji, osobe s 40% u ukupnom poretku tjelesne površine opeklina su pokupili da se konvencionalni spali njegu plus oxandrolone, ili bez oxandrolone.

In a randomized, double-blind study, patients with 40% complete body area burns were chosen to receive conventional burn care plus oxandrolone, or without oxandrolone.
U randomiziranoj, dvostruko slijepoj studiji, bolesnici s 40% ukupno površine tijela opeklinama, odabrani su za primanje konvencionalne brigu topljenju plus oxandrolone, ili bez oxandrolone.

In a randomized, double-blind study, patients with 40% complete body area burns were picked to get standard melt care plus oxandrolone, or without oxandrolone.
U randomiziranom, dvostruko slijepom istraživanju studiji, osobe s 40% u ukupnom poretku tjelesne površine opeklina su pokupili da se konvencionalni spali njegu plus oxandrolone, ili bez oxandrolone.

In a randomized, double-blind study, clients with 40% overall body area burns were chosen to receive common shed care plus oxandrolone, or without oxandrolone.
U randomiziranom, dvostruko slijepom istraživanju studiji, osobe s 40% završena tjelesne površine opeklina odabrani su kako bi dobili tipičnu liječenju opekotina plus oxandrolone, ili bez oxandrolone.

In a randomized, double-blind study, people with 40% total body area burns were chosen to get conventional melt treatment plus oxandrolone, or without oxandrolone.
U randomiziranom, dvostruko slijepom istraživanju studiji, osobe s 40% u ukupnom poretku tjelesne površine opeklina su pokupili da se konvencionalni spali njegu plus oxandrolone, ili bez oxandrolone.

In a randomized, double-blind study, people with 40% total body area burns were picked to obtain common shed care plus oxandrolone, or without oxandrolone.
U randomiziranom, dvostruko slijepom istraživanju studiji, osobe s 40% u ukupnom poretku tjelesne površine opeklina odabrani su kako bi dobili tipičnu prolivenu tretman plus oxandrolone, ili bez oxandrolone.

In a randomized, double-blind study, patients with 40% total body surface area burns were picked to receive standard shed treatment plus oxandrolone, or without oxandrolone.
U randomiziranoj, dvostruko slijepoj studiji, bolesnici s 40% ukupno površine tijela opeklinama, odabrani su za primanje konvencionalne brigu topljenju plus oxandrolone, ili bez oxandrolone.

In a randomized, double-blind study, clients with 40% overall body surface area burns were selected to obtain standard shed treatment plus oxandrolone, or without oxandrolone.
U randomiziranoj, dvostruko slijepoj studiji, bolesnici s 40% ukupno površine tijela opeklinama, odabrani su za primanje konvencionalne brigu topljenju plus oxandrolone, ili bez oxandrolone.

In a randomized, double-blind study, patients with 40% overall body area burns were chosen to get conventional burn treatment plus oxandrolone, or without oxandrolone.
U randomiziranom, dvostruko slijepom istraživanju, bolesnici s 40% u ukupnom poretku tjelesne površine opeklina, odabrani su kako bi dobili zajedničku brigu topljenju plus oxandrolone, ili bez oxandrolone.

In a randomized, double-blind study, clients with 40% complete body surface area burns were selected to receive basic melt care plus oxandrolone, or without oxandrolone.
U randomiziranom, dvostruko slijepom istraživanju, bolesnici s 40% u ukupnom poretku tjelesne površine opeklina, odabrani su kako bi dobili zajedničku brigu topljenju plus oxandrolone, ili bez oxandrolone.

In a randomized, double-blind study, clients with 40% total body area burns were picked to receive conventional burn treatment plus oxandrolone, or without oxandrolone.
U randomiziranom, dvostruko slijepom istraživanju studiji, osobe s 40% u ukupnom poretku tjelesne površine opeklina odabrani su kako bi dobili tipičnu prolivenu tretman plus oxandrolone, ili bez oxandrolone.

In a randomized, double-blind study, individuals with 40% total body surface area burns were chosen to obtain typical burn care plus oxandrolone, or without oxandrolone.
U randomiziranom, dvostruko slijepom istraživanju studiji, osobe s 40% u ukupnom poretku tjelesne površine opeklina odabrani su kako bi dobili tipičnu prolivenu tretman plus oxandrolone, ili bez oxandrolone.

In a randomized, double-blind study, patients with 40% overall body surface area burns were selected to receive standard shed care plus oxandrolone, or without oxandrolone.
U randomiziranom, dvostruko slijepom istraživanju, bolesnici s 40% u ukupnom poretku tjelesne površine opeklina, odabrani su kako bi dobili zajedničku brigu topljenju plus oxandrolone, ili bez oxandrolone.

In a randomized, double-blind study, individuals with 40% complete body surface area burns were selected to receive conventional melt care plus oxandrolone, or without oxandrolone.
U randomiziranom, dvostruko slijepom istraživanju studiji, osobe s 40% u ukupnom poretku tjelesne površine opeklina su pokupili da se konvencionalni spali njegu plus oxandrolone, ili bez oxandrolone.